Companies › JANX

JANUX THERAPEUTICS INC (JANX)

Institutional ownership, SEC filings and insider activity

Sector: Healthcare & Pharma · SEC CIK 0001817713 · EDGAR filings · Updated 2026-07-28

JANUX THERAPEUTICS INC (JANX) has reported institutional ownership of 97.7%, with 189 institutional managers holding positions valued at $827.8M per the latest 13F reporting period. SEC filings include an active notice of delisting or failure to satisfy a continued listing rule (8-K Item 3.01), substantial-doubt (going concern) disclosure per the filings.

Filings this week (1)

• 2026-07-28 — SCHEDULE 13G/A filed

Every filing links to the official SEC document. Real-time filing alerts for this company are available inside the app.

Latest updates

• 2026-07-10 — Insider transaction reported (Form 4)
• 2026-06-23 — Current report (8-K) filed
• 2026-06-12 — Insider transaction reported (Form 4)
• 2026-06-12 — Insider transaction reported (Form 4)
• 2026-06-12 — Insider transaction reported (Form 4)

Institutional ownership overview

According to SEC 13F filings tracked by Sightfile, JANUX THERAPEUTICS INC has 189 institutional holders and institutional ownership of 97.7%.

Insider activity

Insiders reported 36 transactions (0 buys, 13 sells) across 17 reporting insiders, with a net reported value of −$1.18M.

Data flags from SEC filings

Related companies

INHIBRX BIOSCIENCES INC (INBX) · SONIDA SENIOR LIVING INC (SNDA) · UROGEN PHARMA LTD (URGN) · THERAVANCE BIOPHARMA INC (TBPH) · EVOMMUNE INC (EVMN) · PHATHOM PHARMACEUTICALS INC (PHAT)